(Q33811572)

29 July 2017

1 reference

title

Mechanisms of myeloma cell growth control (English)

1 reference

29 July 2017

1 reference

Jelinek DF

1

1 reference

29 July 2017

publication date

1 December 1999

1 reference

Hematology / Oncology Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

13

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

1145-1157

1 reference

Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Human B cell interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Nuclear signaling by interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

The insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Characterization, regulation, and function of specific cell membrane receptors for insulin-like growth factor I on bone endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Interleukin 6 is essential for in vivo development of B lineage neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Distinct short-lived and long-lived antibody-producing cell populations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Prolactin, growth hormone, and insulin-like growth factor-I in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Molecular and cellular aspects of the insulin-like growth factor I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Interleukin-6 inhibits apoptosis of malignant plasma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Interleukin-10 induces interleukin-11 responsiveness in human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Humoral immunity due to long-lived plasma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Adhesion of multiple myeloma cells to the bone marrow microenvironment: implications for future therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Interleukin-6 dependence of advanced malignant plasma cell dyscrasias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970117-9

7 January 2021

10.1016/S0889-8588(05)70117-9

Identifiers

DOI

1 reference

29 July 2017

1 reference